InfoLogix to Present at ROTH Capital Partners 3rd Semi-Annual Software Investor Event

HATBORO, Pa., June 10 /PRNewswire-FirstCall/ -- InfoLogix, Inc. NASDAQ: IFLG, a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today that David Gulian, President and CEO, will present at the ROTH Capital Partners 3rd Semi-Annual Software Investor Event. The conference will be hosted at the St. Regis San Francisco from June 11th-12th, 2008. Mr. Gulian will present on Wednesday, June 11th at 6:45 a.m. PDT.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071101/NETH165LOGO )

InfoLogix's advanced mobility solutions and software have been selected by more than 1,400 hospitals and 800 commercial organizations, including 47 of the Fortune 500, to improve productivity, efficiency and revenues.

For those who cannot attend in person, electronic versions of the presentation can be received via email, fax or postal service by contacting InfoLogix's investor relations department at the address provided at the end of this release.

ROTH Conferences are among the largest in the nation for micro and small cap companies. ROTH combines company presentations, Q&A sessions and management one-on-one meetings so that institutional clients can have an in-depth look at company senior management and issues affecting the growth of the presenting companies.

About InfoLogix, Inc.

InfoLogix is a leading provider of enterprise mobility and advanced wireless asset tracking solutions for the healthcare and commercial industries. InfoLogix uses the industry's most advanced technologies to increase the efficiency, accuracy, and transparency of complex business and clinical processes. With 19 issued patents, InfoLogix provides mobile managed solutions, on-demand software applications, mobile infrastructure products, and strategic consulting services to over 2,000 clients in North America including Kraft Foods, Merck and Company, General Electric, Kaiser Permanente, MultiCare Health System and Stanford School of Medicine. InfoLogix is a publicly-traded company NASDAQ: IFLG. For more information, visit http://www.infologix.com